Uveitis - Pipeline Insight, 2019 - ResearchAndMarkets.com
The "Uveitis - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
The "Uveitis
- Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's
offering.
Uveitis - Pipeline Insight, 2019 offers comprehensive Insight of
the pipeline (under development) therapeutics scenario and growth
prospects across Uveitis development.
The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type.
Pipeline Products covered across the following Developmental
Stages:
- Clinical
- Non-clinical
- Inactive: Discontinued and/or Dormant
Pipeline therapeutics development coverage provides descriptive product
profiles including (but not limited to) drug description, product
development and R&D activities encompassing clinical and pre-clinical
studies, designations, collaborations, licensing deals, grants,
technologies and patent details.
The report assesses the active Uveitis pipeline products by
developmental stage, product type, molecule type, and administration
route.
Reasons to Buy
-
Establish comprehensive understanding of the pipeline activity across
this Uveitis to formulate effective R&D strategies -
Gather information of the emerging competitors having potentially
lucrative portfolio in this space and create effective counter
strategies to gain competitive advantage -
Identify the relationship between the drugs and use it for target
finding, drug repurposing, and precision medicine -
Plot corrective measures for pipeline projects by understanding the
pipeline depth and focus of Uveitis therapeutics -
Devise in licensing and out licensing strategies by identifying
prospective partners with the most attractive projects to enhance and
expand business potential and scope -
Modify the therapeutic portfolio by identifying inactive projects and
understanding the factors that might have halted their progress
Topics Covered
1. Report Introduction
2. Uveitis Overview
3. Pipeline Therapeutics
- An Overview of Pipeline Products for Uveitis
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
- Product Description
- Research and Development
- Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
- Product Description
- Research and Development
- Product Development Activities
7. Therapeutic Assessment
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
- Product Description
- Research and Development
-
Product Development Activities
Companies Featured
- Alcon Pharmaceuticals
- Aldeyra Therapeutics
- Anvil Biosciences
- Apitope International N.V.
- Bionomics Ltd.
- Can Fite Biopharma
- Charlesson LLC
- E&B Technologies
- Elasmogen
- Eleven Biotherapeutics
- Enzo Biochem
- Eyegate Pharma
- Eyevensys
- HanAll Biopharma
- Inflamalps SA
- KPI Therapeutics
- Midatech Pharma
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/b4rqql/uveitis?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20190311005411/en/